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Background: The best treatment options for walled-off pancreatic necrosis (WOPN) are not well defined.
A retrospective study of patients treated for WOPN with transgastric debridement and internal drainage
was undertaken.
Methods: Patients with symptomatic non-infected WOPN treated with open transgastric debridement
and internal drainage were evaluated.
Results: In all, 51 patients underwent surgical management of necrotizing pancreatitis during the study
period. Ten patients (19%) were treated with open transgastric debridement and internal drainage for
symptomatic non-infected WOPN. The median patient age was 40 years, the most common aetiology for
pancreatitis was biliary, the mean American Society of Anesthesiologists (ASA) score was 2 and the delay
to surgery was 100 days. The operating time was 118 min, with a blood loss of 50cc. One patient required
reoperation, three patients had morbidity and there were no mortalities. The only factor associated with
post-operative morbidity was the presence of positive cultures (P < 0.05). The length of stay (LOS) after
surgery was 8 days, at a median follow-up of 18 months, one patient had late complications related to the
surgery and the procedure was successful in 90% of the patients.
Discussion: Open transgastric debridement with internal drainage of WOPN is safe and efficacious.
Patients were clinically stable (no organ failure) and had a long delay in surgical intervention (100 days).
In this select group of patients, the success, morbidity and mortality is similar to all reported minimally
invasive techniques.
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Introduction
The term walled-off pancreatic necrosis (WOPN) also referred to
as post-necrosis pseudocyst, necroma or pancreatic sequestration
was introduced at an American Gastroenterology Association
symposium in 2006.1 WOPN represents the late stages of an acute
post-necrotic collection (APNC), which contains both fluid and
necrotic material formed during the acute phase of severe acute
pancreatitis. With time, APNC matures and a distinct wall devel-
ops between the areas of necrosis and the adjacent tissue. WOPN
may be infected or sterile and diagnosis is established clinically
and with the utilization of radiographic modalities. The most
common indication for the treatment of pancreatic necrosis is
suspected infection.2,3 In addition, patients with non-infected
WOPNmay be persistently unwell or have recurrent disease mani-
festing with pain, fever, feeding intolerance and poor quality of life
(QOL) necessitating surgical intervention.4 The treatments vary
from open debridement with external drainage to minimally inva-
sive techniques with disparate outcomes.5,6
Reports describing the treatment of pancreatic necrosis have
included a heterogenous group of patients and have not separated
patients with symptomatic non-infected WOPN from those with
suspected infection or infected WOPN.3,4,7 The purpose of the
present study was to evaluate a technique in the late management
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of symptomatic non-infected WOPN, open transgastric debride-
ment and internal drainage. Open pseudocystogastrostomy is an
accepted surgical intervention for simple pancreatic pseudocysts
where it has been shown to be effective and associated with good
outcomes.8,9 Modifying this technique for treatingWOPN has not
been described. We report our experience with an emphasis on
pre-operative patient characteristics, and peri-operative and long-
term outcomes. We hypothesis that open transgastric debride-
ment with internal drainage is an effective option associated with
similar outcomes to other previously described techniques for the
management of WOPN.
Methods
Patients admitted or referred for surgical management of pancre-
atic necrosis at the Foothills Medical Center and Peter Loughheed
Medical Center between July 2003 and July 2009 were identified.
These patients were identified from the medical records depart-
ment. A retrospective chart review of patients managed with open
surgery for pancreatic necrosis was undertaken. Patients with
infected or suspected infection undergo open necrosectomy and
drainage. Infected necrotic tissue is defined as a positive culture of
pancreatic or peripancreatic necrotic tissue obtained by means of
fine-needle aspiration or the presence of gas in the fluid collection
on contrast-enhanced computed tomography (CT). Suspected
infected necrosis is defined as persistent sepsis or progressive clini-
cal deterioration despite maximal support in the intensive care
unit (ICU), without documentation of infected necrosis. Patients
with symptomatic non-infected pancreatic necrosis undergo
transgastric debridement and internal drainage. Pancreatic necro-
sis was identified on CT, magnetic resonance imaging (MRI),
contrast = enhanced ultrasound (US) and clinical criteria as
defined by the Atlanta international symposium1 as well as by the
operative findings. Only patients with radiographic evidence of
pancreatic necrosis followed by the development of a well-
circumscribed pancreatic collection associated with necrosis
and operative findings of pancreatic necrosis were included in
the present study. Patients with predominantly fluid-filled
pseudocysts and small areas of necrosis were not included in this
study. Therefore, only patients with substantial areas of necrosis,
>75% of the WOPN were considered for this surgical approach
and all had areas of pancreatic necrosis at the time of surgery.
Management of patients with substantial fluid components were
often managed by endoscopic drainage. Patient demographics,
aetiology of the pancreatitis, length of initial hospitalization, need
for parenteral nutrition or nasojejunal tube feedings, previous
interventions and indications and timing of surgery were
obtained. Specific indications for therapy were clinically persistent
pancreatitis or persistent unwellness as defined by Rattner.10 Clini-
cal manifestations of persistent unwellness included repeated
admissions for mild pancreatitis with subjective complaints of
abdominal pain requiring narcotics, failure to thrive and food
intolerance. Surgical and post-surgical outcomes evaluated
included size and location of WOPN, estimated blood loss, length
of stay (LOS), need for reoperation, morbidity, mortality and
presence of bacteria in the necrosis. In addition to other morbidi-
ties associated with abdominal surgery, specific complications
included in the study were the subsequent need for percutaneous
drain after operative intervention, enteric fistula and pancreatic
fistula. Late complications were defined as complications occur-
ring after 30 days.
Summary data are represented as medians (range). To deter-
mine prognostic variables for morbidity, the chi-square test was
used with P < 0.05 being considered significant. Statistical analysis
was performed using EXCEL (Microsoft Corp., Redmond, WA,
USA).
Surgical technique
A limited upper midline incision was the standard incision. An
anterior gastrotomy is made over the bulge of theWOPN. Using a
large bore needle the area of WOPN is localized and a posterior
gastrotomy made using electrocautery and the area of necrosis is
entered. The posterior gastrotomy is enlarged and using a combi-
nation of blunt finger debridement, sponge sticks as well as irri-
gation and suction a complete debridement is achieved. In large
areas of necrosis a 30-degree laparoscope has been utilized to
visualize the entire cavity and to ensure adequate debridement.
After completing the debridement, the cyst wall and posterior wall
of the stomach is sutured to the inflammatory wall using inter-
rupted 4.0 polydioxone (Ethicon Inc., Somerville, NJ, USA)
sutures. The anterior gastrotomy is subsequently closed after
nasogastric tube placement.
Results
Patient characteristics
During the study period, a total of 51 patients were treated for
pancreatic necrosis. In all, 41 patients underwent an exploratory
laparotomy with necrosectomy and closed drainage as described
by Fernandez et al.3 Ten patients (9.6 % of all patients) had a
diagnosis of symptomatic non-infected WOPN and were treated
with transgastric debridement and internal drainage. The median
age was 40 years, 6 were female. The aetiology of the pancreatitis
was biliary in six and alcoholic in four. The indication for surgery
based on the clinical course was persist pancreatitis in four and
recurrent in six patients. The patients with persistent pancreatitis
all required prolonged hospitalization and were unwell with fevers
and pain, whereas the patients with recurrent pancreatitis were
often discharged after their episode of pancreatitis but had symp-
toms related toWOPN with the most common being pain requir-
ing narcotic administration and failure to thrive. All but one
patient had weight loss associated with pancreatitis (median
weight loss of 25 lbs). No patients required ICU care at the time of
surgery. The median time from presentation with pancreatitis to
definitive surgical management was 100 days, and 4 patients had
significant comorbidities at the time of surgical intervention. The
mean American Society of Anesthesiologists (ASA) score was 2
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(Table 1).As a result of the fact that most patients were transferred
into our institution or referred after the initial episode of pancre-
atitis we could not obtain a Ranson or APACHE score.
WOPN characteristics
WOPN characteristics are shown in Table 2. The median maximal
diameter of WOPN on CT scan was 14 cm. In six patients,WOPN
was located in the body and tail of the pancreas, two involved the
entire pancreas, one the body and head and one the body only. In
four patients there was extension to the paracolic gutters. Two
patients had prior endoscopic attempts at treating the area of
pancreatic necrosis: one patient had had endoscopic cystogastros-
tomy without resolution of the symptoms and the other had had
endoscopic ultrasound (EUS)-guided tube drainage with similar
outcomes. Bacterial cultures taken in the operating room grew
bacteria and/or fungi in four patients, with enterococcus sp. being
the most common. Splenic vein thrombosis was present in half of
the cases, but there was no clinical or radiographic evidence of
gastric varices in any patient.
Peri-operative outcome
All patients underwent successful transgastric debridement
without mortality and six of the patients also underwent a chole-
cystectomy (Table 3). The operative time was 118 (60–270) min
and the estimated blood loss was 50 ml (50–750). No patient
required post-operative ICU admission and the median LOS was
8 days. Three patients had early post-operative morbidity involv-
ing wound infection treated with local debridement. One patient
required reoperation for further debridement of the WOPN via a
retroperitoneal incision and this was complicated by a gastric
fistula. One patient developed a symptomatic intra-abdominal
fluid collection that resolved with percutaineous drainage. The
only factor associated with the development of early post-
operative morbidity was positive cavity cultures at debridement,
P < 0.05. At a mean follow-up of 18 months, two patients experi-
enced late complications: development of a recurrent abscess in
the retroperitoneum related to the gastric fistula and recurrent
pseudocyst 3 years after resolution of WOPN associated with
ongoing alcohol abuse and chronic pancreatitis. Pre-operative
Table 1 Patient characteristics
Patient Age Gender Aetiology Clinical
course
Symptoms Weight
loss
(lbs)
ICU
stay
Time to
surgery
(days)
Comorbities
1 39 m Alcohol Recurrent Early satiety 0 No 273 Smoker
2 42 f Biliary Persistent Pain 10 No 40 No
3 79 f Biliary Recurrent Pain 30 Yes 206 DM, HTN
4 51 m Alcohol Recurrent Pain 50 Yes 184 CAD
5 29 f Biliary Recurrent Pain 30 Yes 122 No
6 22 m Alcohol Persistent Pain, FTT 30 Yes 77 DM, HTN
7 41 f Biliary Recurrent Pain 20 No 90 No
8 36 f Biliary Persistent Pain, FTT, fevers 40 No 110 No
9 51 m Alcohol Persistent Pain, FTT, fevers 20 No 48 No
10 33 f Biliary Recurrent Pain, FTT 10 No 88 DM
ICU, intensive care unit; FTT, failure to thrive; DM, diabetes mellitus; HTN, hypertension; CAD, coronary artery disease.
Table 2 WOPN characteristics
Patient Size (cm) Location Gutter
extension
Pre-operative
intervention
Positive cultures
at surgery
Splenic vein
thrombosis
1 10.2 Body, tail No No No Yes
2 14.4 Body, tail No No No No
3 14.4 Body, tail No No No No
4 25 Body, tail Yes No Yes Yes
5 17.2 Complete Yes No No No
6 20 Complete Yes Endoscopic cystgastrostomy Yes Yes
7 12 Body, tail No EUS-guided drainage Yes No
8 12 Body No No Yes No
9 16.3 Body, head Yes No No Yes
10 14 Body, tail No No No No
EUS, endoscopic ultrasound.
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symptoms resolved in 90% of the patients. Eight patients had
post-perative CTs at a median of 2.5 months documenting reso-
lution of their WOPN (Fig. 1).
Discussion
WOPN occurs in the late stage of necrotizing pancreatitis, it is a
distinct entity from a pseudocyst and treatment requires some
form of debridement unlike a pseudocyst where a drainage pro-
cedure is often adequate.11 A conservative approach to patients
with severe acute pancreatitis including a delay in surgery of up to
4 weeks has been shown to be advantageous,2,3 and this has
resulted in fewer patients with necrotizing pancreatitis undergo-
ing early surgery leading to an increased incidence in patients
presenting with WOPN.12,13 Recently, a randomized trial demon-
strated that by utilizing a step-up approach for patients with sus-
picion of infection or infected pancreatic necrosis, 35% of patients
did not require a subsequent necrosectomy after initial manage-
ment with percutaneous drainage.14 In our patient population,
81% of patients referred for surgical management of pancreatic
necrosis underwent laparotomy and necrosectomy with closed
drainage for infection or suspected infection. The long-term clini-
cal course of patients managed without necrosectomy or by per-
cutaneous drainage only is unknown and it is unclear how many
will become symptomatic and require an intervention.However, it
is clear that many patients with necrotizing pancreatitis have a
poor QOL even after non-surgical management and are persis-
tently unwell with repeated admissions or visits to the physician
with failure to thrive manifested primarily by poor oral intake and
pain.15,16 Some of these patients may have persistent WOPN
without systemic or radiologic signs of infection. In all, 19% of all
patients referred for surgical management of pancreatic necrosis
at our institution comprised this group of stable elective patients
with long delays before intervention and without evidence of
organ failure or suspected infection. Treatment of symptomatic-
infected WOPN involves open debridement with external drain-
age and recently several centres have reported new minimally
invasive treatment approaches that according to Windsor et al.17
can be classified by the access route (transperitoneal, retroperito-
neal, transgastric) and by the type of scope used (endoscope,
laparoscope or nephroscope).
Our experience with open transgastric debridement and inter-
nal drainage in a well-selected group of patients with symptom-
atic non-infected WOPN has proven to be effective and highly
successful in the management of this challenging medical condi-
tion. It appears to be similar to other techniques with acceptable
morbidity and LOS with long-term success of 90% at a median
follow-up of 18 months. There are several technical limitations to
the utilization of this technique: lack of apposition of the gastric
wall to the WOPN could complicate the operation and lead to a
gastric fistula, inadequate necrosectomy at the initial operation
could require subsequent drainage via a different approach and
lead to a gastric fistula, which occurred in one of our patients
causing multiple retroperitoneal abscess related to this issue.
Therefore in patients with extensive paracolic gutter extension this
technique should only be used in those instances where a com-
Table 3 Peri-operative data and treatment outcomes
Operative time (minutes) 118 (60–270)
Estimated blood loss (mls) 150 (50–750)
Cholecystectomy 6/10
ICU stay 0
Length of stay 8.8 (6–16)
Complications 3 patients (33%)
Re-operation 1 patient (10%)
Late complications 2 patients (20%)
Mortality 0
Median follow-up (months) 18
Symptom resolution 9/10
ICU, intensive care unit.
Figure 1 Pre-operative and post-operative computed tomography (CT) scan showing resolution of walled-off pancreatic necrosis (WOPN)
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plete debridement can be achieved at the time of initial operation.
Incomplete debridement assessed intra-operatively mandates
external drainage after closure of the gastrotomy. One of the con-
cerns of internally debriding and draining WOPN is that it could
lead to continuous retroperitoneal contamination. However, a
complete debridement should prevent ongoing retroperitoneal
sepsis.
Operative management of pancreatic necrosis involves open
debridement followed by closed packing and/or drainage.
However, morbidity and mortality associated with this technique
is substantial.3,13,18 The reported early mortality associated with
open debridement ranges from 3.7%–39%3,19 and an additional
late mortality of 15%.6 Open debridement is associated with an
incidence of a pancreatico-cutaneous fistula of up to 53% and
enteral fistulae of up to 16%.3,19 Laparoscopic or hybrid tech-
niques that utilize wide external drainage also have high rates of
fistulae formation. Parekh et al. reported on 19 patients who
underwent a hand-assisted laparoscopic necrosectomy with a
mortality rate of 10%,morbidity of 28% and need for laparotomy
in 15%. The pancreatic fistula rate in that study was 67% deter-
mined by drain amylase levels20 Most of the reports on the man-
agement of WOPN with open necrosectomy have included a large
majority of patients with infected pancreatic necrosis (54–72%)
which was the primary indication for surgical intervention.3,6,21
This group of patients is a distinct group, different from our
patient population and therefore direct comparison is not pos-
sible.
Retroperitoneal necrosectomy uses a small retroperitoneal inci-
sion or reliance on a pre-operatively placed drain to guide the
placement of the incision. Dilation of the drain tract enables the
placement of a scope that can be used for debridement. In a recent
review of 141 patients treated with retroperitoneal necrosectomy,
the mortality was 16%, morbidity was 41%, 2–8 procedures per
patient were required and there was a 13% need for subsequent
laparotomy.5,22,23 In the randomized trial where retroperitoneal
minimally invasive necrosectomy was used as the next step up
after percutaneous drainage, the median number of procedures
was one per patient.14
Endoscopic management of WOPN has become an option in
some specialized centres. Simple endoscopic drainage of WOPN
has been found to be ineffective when compared with endoscopic
necrosectomy (45% vs. 88%) and simple drainage required more
procedures and the LOS was longer.11 Therefore, some form of
necrosectomy is recommended. The endoscopic necrosectomy
technique involves creation of a transgastric or transduodenal
pseudocyst tract that is subsequently dilated to allow for debride-
ment. A minimum of three procedures is required with a hospital
stay of 5–13 days. These endoscopic techniques are associated with
major morbidity of 20%, mortality of 5% and the need for lap-
arotomy in 0–23% of patients.4,5,11,24
The primary advantage of transgastric drainage compared with
open, laparoscopic debridement or retroperitoneal debridements,
which all utilize external drainage, is the reduction in the pancre-
atic fistula rate which can be associated with significant morbidity
and mortality.25 Some reports recommend that a pre-operative
endoscopic retrograde cholangiopancreatography (ERCP) would
better define the group of patients with pancreatic duct injury and
therefore favour internal drainage.26,27 The disadvantage of retro-
peritoneal necrosectomy is that it often requires multiple proce-
dures for a complete necresectomy compared with one definitive
procedure for the transgastric technique.22,23,28,29 Open transgastric
debridement and internal drainage appears to have similar mor-
bidity, reduced LOS and no mortality compared with the endo-
scopic management of WOPN with the advantage of requiring
fewer procedures and a reduced length of hospitalization.4,28
Several factors have been found to be predictive of failure in the
endoscopic management of WOPN: extension into the paracolic
gutters, size >15 cm and the presence of diabetes mellitus.4 Given
the limited size of the present study, factors predictive of failure
could not be identified. The patient with a poor outcome had all
three of these factors. However, patients with one or two of these
factors representing 40% of our patients were successfully treated
with our technique. Additionally, this approach enables cholecys-
tectomy to be performed at the time of initial surgery therefore
negating the need for a second operation which may decrease
hospitalization time and cost.
Limitations of the present study are that it is retrospective and
includes a small number of patients with a short follow-up. Also a
cost or a QOL analysis was not performed but are areas that need
further elaboration. Most reports on the treatment of complica-
tions related to necrotizing pancreatitis have included a heteroge-
neous group of patients. The clinical spectrum of patients has
ranged from septic patients with organ failure to stable patients
with recurrent disease manifested by pain and/or failure to thrive.
Therefore any direct comparison between different techniques is
plagued by clinical heterogeneity.14,20,30 Even although four of our
patients had intra-operative cultures that were positive, two had
prior instrumentation and the other two may be related to con-
tamination as cultures were taken after the stomach was opened.
None of our patients had clinical or radiographic signs and symp-
toms of infection pre-operatively.
The natural history of patients with symptomatic non-infected
WOPN or patients who were managed without necrosectomy for
suspected infected WOPN is unknown. Over time, patients may
experience resolution of the necrosum and therefore not require
intervention for symptoms. Longitudinal studies on these patients
will determine the need for surgery. A definitive conclusion
regarding this technique requires a larger prospective study which
in addition to clinical resolution should also include a cost and
QOL analysis as some of the outcomemeasures so as to determine
the preferred approach for treating this group of patients. An
effort should also be made to separate patients with symptomatic
non-infected WOPN from those with suspected or infected pan-
creatic necrosis when reporting on techniques used in the man-
agement of WOPN because their outcomes are different. In a
group of stable patients with persistent symptoms from non-
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infected WOPN, remote from their episode of pancreatitis, open
transgastric debridement and internal drainage is a reasonable
surgical option and may be a useful option in centres without
experience in minimally invasive techniques.
Conflicts of interest
None declared.
References
1. Bollen TL, van Santvoort HC, Besselink MG, van Leeuwen MS, Horvath
KD, Freeny PC et al. (2008) The Atlanta Classification of acute pancre-
atitis revisited. Br J Surg 95:6–21.
2. Besselink MG, Verwer TJ, Schoenmaeckers EJ, Buskens E, Ridwan BU,
Visser MR et al. (2007) Timing of surgical intervention in necrotizing
pancreatitis. Arch Surg 142:1194–1201.
3. Fernandez-del Castillo C, Rattner DW, Makary MA, Mostafavi A, McGrath
D, Warshaw AL. (1998) Debridement and closed packing for the treat-
ment of necrotizing pancreatitis. Ann Surg 228:676–684.
4. Papachristou GI, Takahashi N, Chahal P, Sarr MG, Baron TH. (2007)
Peroral endoscopic drainage/debridement of walled-off pancreatic
necrosis. Ann Surg 245:943–951.
5. Babu BI, Siriwardena AK. (2009) Current status of minimally invasive
necrosectomy for post-inflammatory pancreatic necrosis. HPB 11:96–
102.
6. Babu BI, Sheen AJ, Lee SH, O'Shea S, Eddleston JM, Siriwardena AK.
(2010) Open Pancreatic Necrosectomy in the Multidisciplinary Manage-
ment of Postinflammatory Necrosis. Ann Surg.
7. Hookey LC, Debroux S, Delhaye M, Arvanitakis M, Le Moine O, Deviere
J. (2006) Endoscopic drainage of pancreatic-fluid collections in 116
patients: a comparison of etiologies, drainage techniques, and out-
comes. Gastrointest Endosc 63:635–643.
8. Melman L, Azar R, Beddow K, Brunt LM, Halpin VJ, Eagon JC et al.
(2009) Primary and overall success rates for clinical outcomes after
laparoscopic, endoscopic, and open pancreatic cystgastrostomy for
pancreatic pseudocysts. Surg Endosc 23:267–271.
9. Parks RW, Tzovaras G, Diamond T, Rowlands BJ. (2000) Management of
pancreatic pseudocysts. Ann R Coll Surg Engl 82:383–387.
10. Rattner DW, Legermate DA, Lee MJ, Mueller PR, Warshaw AL. (1992)
Early surgical debridement of symptomatic pancreatic necrosis is ben-
eficial irrespective of infection. Am J Surg 163:105–109; discussion 109–
110.
11. Gardner TB, Chahal P, Papachristou GI, Vege SS, Petersen BT, Gostout
CJ et al. (2009) A comparison of direct endoscopic necrosectomy with
transmural endoscopic drainage for the treatment of walled-off pancre-
atic necrosis. Gastrointest Endosc 69:1085–1094.
12. Hungness ES, Robb BW, Seeskin C, Hasselgren PO, Luchette FA. (2002)
Early debridement for necrotizing pancreatitis: is it worthwhile? J Am Coll
Surg 194:740–744; discussion 744–745.
13. Heinrich S, Schafer M, Rousson V, Clavien PA. (2006) Evidence-based
treatment of acute pancreatitis: a look at established paradigms. Ann
Surg 243:154–168.
14. van Santvoort HC, Besselink MG, Bakker OJ, Hofker HS, Boermeester
MA, Dejong CH et al. (2010) A step-up approach or open necrosectomy
for necrotizing pancreatitis. N Engl J Med 362:1491–1502.
15. Wright SE, Lochan R, Imrie K, Baker C, Nesbitt ID, Kilner AJ et al. (2009)
Quality of life and functional outcome at 3, 6 and 12 months after acute
necrotising pancreatitis. Intensive Care Med 35:1974–1978.
16. Szentkereszty Z, Agnes C, Kotan R, Gulacsi S, Kerekes L, Nagy Z et al.
(2004) Quality of life following acute necrotizing pancreatitis. Hepatogas-
troenterology 51:1172–1174.
17. Windsor JA. (2007) Minimally invasive pancreatic necrosectomy. Br J
Surg 94:132–133.
18. Beattie GC, Mason J, Swan D, Madhavan KK, Siriwardena AK. (2002)
Outcome of necrosectomy in acute pancreatitis: the case for continued
vigilance. Scand J Gastroenterol 37:1449–1453.
19. Connor S, Alexakis N, Raraty MG, Ghaneh P, Evans J, Hughes M et al.
(2005) Early and late complications after pancreatic necrosectomy.
Surgery 137:499–505.
20. Parekh D. (2006) Laparoscopic-assisted pancreatic necrosectomy: a new
surgical option for treatment of severe necrotizing pancreatitis. Arch Surg
141:895–902; discussion 902–903.
21. Rodriguez JR, Razo AO, Targarona J, Thayer SP, Rattner DW, Warshaw
AL et al. (2008) Debridement and closed packing for sterile or infected
necrotizing pancreatitis: insights into indications and outcomes in 167
patients. Ann Surg 247:294–299.
22. Connor S, Ghaneh P, Raraty M, Sutton R, Rosso E, Garvey CJ et al.
(2003) Minimally invasive retroperitoneal pancreatic necrosectomy. Dig
Surg 20:270–277.
23. Chang YC, Tsai HM, Lin XZ, Chang CH, Chuang JP. (2006) No debride-
ment is necessary for symptomatic or infected acute necrotizing pancre-
atitis: delayed, mini-retroperitoneal drainage for acute necrotizing
pancreatitis without debridement and irrigation. Dig Dis Sci 51:1388–
1395.
24. Voermans RP, Veldkamp MC, Rauws EA, Bruno MJ, Fockens P. (2007)
Endoscopic transmural debridement of symptomatic organized pancre-
atic necrosis (with videos). Gastrointest Endosc 66:909–916.
25. Nair RR, Lowy AM, McIntyre B, Sussman JJ, Matthews JB, Ahmad SA.
(2007) Fistulojejunostomy for the management of refractory pancreatic
fistula. Surgery 142:636–642; discussion 642.e1.
26. Nealon WH, Bhutani M, Riall TS, Raju G, Ozkan O, Neilan R. (2009)
A unifying concept: pancreatic ductal anatomy both predicts and deter-
mines the major complications resulting from pancreatitis. J Am Coll Surg
208:790–799; discussion 799–801.
27. Nealon WH, Walser E. (2002) Main pancreatic ductal anatomy can direct
choice of modality for treating pancreatic pseudocysts (surgery versus
percutaneous drainage). Ann Surg 235:751–758.
28. Navaneethan U, Vege SS, Chari ST, Baron TH. (2009) Minimally invasive
techniques in pancreatic necrosis. Pancreas 38:867–875.
29. Connor S, Raraty MG, Howes N, Evans J, Ghaneh P, Sutton R et al.
(2005) Surgery in the treatment of acute pancreatitis – minimal access
pancreatic necrosectomy. Scand J Surg 94:135–142.
30. van Santvoort HC, Besselink MG, Horvath KD, Sinanan MN, Bollen TL,
van Ramshorst B et al. (2007) Videoscopic assisted retroperitoneal debri-
dement in infected necrotizing pancreatitis. HPB 9:156–159.
HPB 239
HPB 2011, 13, 234–239 © 2011 International Hepato-Pancreato-Biliary Association
